Hologic/HOLX

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Hologic

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Ticker

HOLX

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Marlborough, United States

Employees

6,990

Hologic Metrics

BasicAdvanced
$17B
Market cap
38.57
P/E ratio
$1.91
EPS
1.01
Beta
-
Dividend rate
$17B
1.01
3.969
2.97
51.897
52.669
7.92%
6.22%
9.20%
38.57
4.49
3.59
21.71
18.72
-2.37%
-36.42%
-9.35%
-36.02%

What the Analysts think about Hologic

Analyst Ratings

Majority rating from 18 analysts.
Buy

Hologic Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
16.69% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$1B
0.46%
Net income
$170M
-31.08%
Profit margin
16.69%
-31.40%

Hologic Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 5.37%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.93
$0.89
$0.98
$1.03
-
Expected
$0.89
$0.84
$0.95
$0.98
$1.02
Surprise
4.43%
5.86%
3.03%
5.37%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Hologic stock?

Hologic (HOLX) has a market cap of $17B as of July 03, 2024.

What is the P/E ratio for Hologic stock?

The price to earnings (P/E) ratio for Hologic (HOLX) stock is 38.57 as of July 03, 2024.

Does Hologic stock pay dividends?

No, Hologic (HOLX) stock does not pay dividends to its shareholders as of July 03, 2024.

When is the next Hologic dividend payment date?

Hologic (HOLX) stock does not pay dividends to its shareholders.

What is the beta indicator for Hologic?

Hologic (HOLX) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Hologic stock

Buy or sell Hologic stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing